env Gene Products, Human Immunodeficiency Virus
"env Gene Products, Human Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins encoded by the ENV GENE of the HUMAN IMMUNODEFICIENCY VIRUS.
MeSH Number(s)
D12.776.964.775.325.164
D12.776.964.775.562.500
D12.776.964.970.880.325.164
Below are MeSH descriptors whose meaning is more general than "env Gene Products, Human Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "env Gene Products, Human Immunodeficiency Virus".
This graph shows the total number of publications written about "env Gene Products, Human Immunodeficiency Virus" by people in Harvard Catalyst Profiles by year, and whether "env Gene Products, Human Immunodeficiency Virus" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 6 | 7 |
| 2009 | 5 | 3 | 8 |
| 2010 | 4 | 2 | 6 |
| 2011 | 8 | 4 | 12 |
| 2012 | 5 | 7 | 12 |
| 2013 | 9 | 6 | 15 |
| 2014 | 13 | 8 | 21 |
| 2015 | 7 | 6 | 13 |
| 2016 | 10 | 2 | 12 |
| 2017 | 8 | 9 | 17 |
| 2018 | 11 | 6 | 17 |
| 2019 | 17 | 9 | 26 |
| 2020 | 12 | 6 | 18 |
| 2021 | 8 | 5 | 13 |
| 2022 | 3 | 4 | 7 |
Below are the most recent publications written about "env Gene Products, Human Immunodeficiency Virus" by people in Profiles.
-
Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection. J Virol. 2022 12 21; 96(24):e0127022.
-
Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs. Clin Infect Dis. 2022 10 12; 75(8):1342-1350.
-
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice. Immunity. 2022 11 08; 55(11):2168-2186.e6.
-
Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound. J Virol. 2022 09 14; 96(17):e0063622.
-
Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation. J Virol. 2022 04 27; 96(8):e0166821.
-
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice. Cell Rep. 2022 03 15; 38(11):110514.
-
Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller. J Exp Med. 2022 03 07; 219(3).
-
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial. J Clin Invest. 2021 12 01; 131(23).
-
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env. Sci Transl Med. 2021 11 24; 13(621):eabk1533.
-
SOSIP Trimer-Specific Antibodies Isolated from a Simian-Human Immunodeficiency Virus-Infected Monkey with versus without a Pre-blocking Step with gp41. J Virol. 2022 01 26; 96(2):e0158221.